ScoreWhy is Bafna Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 8.26%
- Poor long term growth as Operating profit has grown by an annual rate 17.34% of over the last 5 years
2
With ROCE of 5.7, it has a Expensive valuation with a 3.5 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 81.47%, its profits have risen by 980% ; the PEG ratio of the company is 0
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Bafna Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Bafna Pharma.
81.47%
1.56
52.27%
Sensex
4.76%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
20.53%
EBIT Growth (5y)
17.34%
EBIT to Interest (avg)
4.34
Debt to EBITDA (avg)
1.53
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
1.24
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.34%
ROCE (avg)
8.44%
ROE (avg)
10.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
27
Price to Book Value
4.25
EV to EBIT
35.64
EV to EBITDA
24.81
EV to Capital Employed
3.52
EV to Sales
2.71
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
5.74%
ROE (Latest)
12.46%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
PAT(Latest six months)
At Rs 6.51 cr has Grown at 189.33%
OPERATING CF(Y)
Highest at Rs 22.14 Cr
-1What is not working for the Company
NON-OPERATING INCOME(Q)
is 37.82 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Bafna Pharma.
Profit After Tax (PAT) - Latest six months
At Rs 6.51 cr has Grown at 189.33%
Year on Year (YoY)MOJO Watch
PAT trend is very positive
PAT (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 22.14 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Profit After Tax (PAT) - Latest six months
Higher at Rs 6.51 cr
than preceding 12 month period ended Sep 2025 of Rs 6.31 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Here's what is not working for Bafna Pharma.
Non Operating Income - Quarterly
is 37.82 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
